TABLE 2

Pharmacology of DIPT, 5-MeO-DET, and 5-MeO-AMT at 5-HT1A and 5-HT2A receptors: effects on binding and function

For test compounds, n = 3–8 for each assay. Data are expressed as mean ± S.E.M. The standard compounds for purposes of comparison for 5-HT1A binding and functional assays were serotonin and dihydroergotamine. The standard compounds for 5-HT2A binding and functional assays were serotonin and LSD.

AssayDrug
DIPT5-MeO-DET5-MeO-AMTSerotoninDihydroergotamineLSD
5-HT1A binding and functional assay
    [3H]8-OH-DPAT binding Ki, nM2270 ± 60023.8 ± 7.9194 ± 713.42 ± 0.411.01 ± 0.35
    Hill coefficient−1.01 ± 0.15−0.84 ± 0.07−0.83 ± 0.04−0.89 ± 0.10−0.58 ± 0.04
    [35S]GTPγS binding EC50, nM4570 ± 640380 ± 110680 ± 25016.1 ± 5.70.82 ± 0.13
    5-HT maximal effect, %58.1 ± 9.8103.0 ± 6.2100.6 ± 7.910091 ± 24
5-HT2A binding and functional assays
    [125I]DOI binding Ki, nM910 ± 120251 ± 9232.9 ± 5.520.4 ± 4.30.92 ± 0.16
    Hill coefficient−0.72 ± 0.05−0.76 ± 0.08−0.68 ± 0.07−0.70 ± 0.06−1.07 ± 0.13
    [3H]AA release EC50, nM450 ± 22089 ± 343.35 ± 0.9610.3 ± 1.01.01 ± 0.31
    LSD maximal effect, %88 ± 10106 ± 16108 ± 14100
    IP-1 formation EC50, nM420 ± 140280 ± 1208.4 ± 4.449 ± 130.277 ± 0.055
    Serotonin maximal effect, %81.4 ± 3.9102 ± 1184.2 ± 8.799.7 ± 1.483.1 ± 5.6